Meeting Banner
Abstract #1638

Evaluation of MRI as an Outcome Measure for Therapeutic Trials in Muscular Dystrophy Mice

Khan Hekmatyar1, Steven J. Foltz2, Marisa J. Fortunato2, Aaron M. Beedle2

1BioImaging Research Center/Complex Carbohydrate Research Center, University of Georgia, Athens, GA, United States; 2Department of Pharmaceutical and Biomedical Sciences, University of Georgia College of Pharmacy, Athens, GA, United States

Abnormal glycosylation of α-dystroglycan impairs the structural link between the extracellular matrix and the cytoskeleton causing dystroglycanopathy-type muscular dystrophy. There are no validated therapies for dystroglycanopathies and variability in phenotypes complicates the assessment of therapeutic effect. Our aim is to assess the correlation between relaxometric measurements (T2) in magnetic resonance (MR) imaging and histological measurements to determine the reliability and suitability of MR imaging for future therapeutic trials in animal models.

Keywords

able additional analyses analyzed anesthetized animal answer anterior applied applying assessment becoming better biomedical birdcage body canonical carbohydrate central certain chain clear clinical coil collected college complex complicates conditional correlation develop diffusion disease distinction drug dystrophy easily edema elevated embryonic equation evaluation exponential expression facility final gene generated genes goal grant graph heavy histological histology identify indicating indicator inter invest involved issues khan knockout laboratory least like limited linear linearly magnet materials measure measured mice model moderate mono mouse muscle muscles muscular mutations nucleation occurs outcome overcome pathology patients pharmaceutical pharmacy phenotype physiology pixel pixels population predictor prevalent primary processed profiles progression progressive quadriceps quantify quantitative radiology reduction regeneration reliable residual scanned sciences seed severe severely slice slices software spectroscopy spin squares stage stages stained statistical strong suggest suggesting supported tailed targeting therapeutic tibia tools translated treatment trials type understanding underweight useful variability variation versus weak week weeks whereas